We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24.3B
AUM Growth
-$663M
(-2.7%)
Cap. Flow
-$1.37B
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
15.29%
Holding
1,567
New
158
Increased
553
Reduced
532
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$130M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$126M |
| 3 |
MetLife
MET
|
+$107M |
| 4 |
General Mills
GIS
|
+$92.4M |
| 5 |
Parker-Hannifin
PH
|
+$71.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 2 |
RTN
Raytheon Company
RTN
|
+$151M |
| 3 |
Delta Air Lines
DAL
|
+$148M |
| 4 |
Norfolk Southern
NSC
|
+$145M |
| 5 |
Boston Scientific
BSX
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.77% |
| 2 | Financials | 14.55% |
| 3 | Technology | 14.11% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Industrials | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WLL
501
DELISTED
Whiting Petroleum Corporation
WLL
| $6.45M | 0.03% |
695
+571
| +460% | +$5.78M |
|
502
Hershey
HSY
$34.2B
| $6.44M | 0.03% |
63,813
+1,805
| +3% | +$188K |
|
503
IQVIA
IQV
$44.4B
| $6.43M | 0.03% |
96,069
+2,350
| +3% | +$148K |
|
|
BCR
504
DELISTED
CR Bard Inc.
BCR
| $6.41M | 0.03% |
38,325
+17,733
| +86% | +$3.04M |
|
505
Prudential Financial
PRU
$41.2B
| $6.39M | 0.03% |
79,588
+2,008
| +3% | +$163K |
|
506
iShares US Oil & Gas Exploration & Production ETF
IEO
$746M
| $6.38M | 0.03% |
86,990
+3,670
| +4% | +$263K |
|
507
XPO
XPO
$20.9B
| $6.37M | 0.03% |
+404,795
| New | +$5.87M |
|
508
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.5B
| $6.33M | 0.03% |
132,590
+9,220
| +7% | +$436K |
|
|
GNCA
509
DELISTED
Genocea Biosciences, Inc.
GNCA
| $6.29M | 0.03% |
66,297
+36,554
| +123% | +$2.58M |
|
510
Cogent Communications
CCOI
$473M
| $6.29M | 0.03% |
178,000
-170,103
| -49% | -$6.22M |
|
|
ELGX
511
DELISTED
Endologix Inc
ELGX
| $6.28M | 0.03% |
36,807
+194
| +0.5% | +$29.4K |
|
|
SAFM
512
DELISTED
Sanderson Farms Inc
SAFM
| $6.26M | 0.03% |
78,600
-72,800
| -48% | -$5.91M |
|
513
Fidelity National Information Services
FIS
$19.3B
| $6.25M | 0.03% |
91,800
-148,500
| -62% | -$9.71M |
|
514
Verastem
VSTM
$665M
| $6.24M | 0.03% |
+51,148
| New | +$5.36M |
|
515
United Natural Foods
UNFI
$2.7B
| $6.24M | 0.03% |
81,000
-3,400
| -4% | -$266K |
|
516
WEC Energy
WEC
$33.7B
| $6.23M | 0.03% |
125,899
-11,243
| -8% | -$588K |
|
|
ADVM
517
DELISTED
Adverum Biotechnologies
ADVM
| $6.18M | 0.03% |
15,265
+10,913
| +251% | +$4.61M |
|
518
PTC
PTC
$14.4B
| $6.18M | 0.03% |
171,000
+29,000
| +20% | +$1M |
|
519
Chubb
CB
$132B
| $6.15M | 0.03% |
55,139
+4,639
| +9% | +$522K |
|
|
VVC
520
DELISTED
Vectren Corporation
VVC
| $6.14M | 0.03% |
139,018
-233,600
| -63% | -$10.7M |
|
|
SPLK
521
DELISTED
Splunk Inc
SPLK
| $6.07M | 0.03% |
+102,500
| New | +$6.19M |
|
522
Henry Schein
HSIC
$9.75B
| $6.04M | 0.02% |
110,405
+12,862
| +13% | +$706K |
|
523
Qualys
QLYS
$6.41B
| $6.04M | 0.02% |
130,000
-30,000
| -19% | -$1.28M |
|
|
VAR
524
DELISTED
Varian Medical Systems, Inc.
VAR
| $6.03M | 0.02% |
73,057
+436
| +0.6% | +$35K |
|
525
Radware
RDWR
$1.25B
| $6M | 0.02% |
287,000
+12,000
| +4% | +$255K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2015 Portfolio in Review
As of Q1 2015, Axa held 1,567 positions worth $24.3B, down 2.7% from $24.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Axa withdrew a net $1.37B in Q1 2015, closing 145 positions and reducing 532 holdings. Its most notable exit was Viatris, an estimated $55.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
Against the trend, Axa opened a new position in Nasdaq worth $42.1M.
- Axa's largest Q1 2015 buy was Nasdaq: 2,480,223 shares worth $42.1M.
- Axa added most to Johnson & Johnson in Q1 2015, an estimated $130M increase.
- Axa's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $199M.
- Axa fully exited Viatris in Q1 2015, selling an estimated $55.8M.
- Axa's ten largest holdings make up 15% of its $24.3B portfolio in Q1 2015.
- Axa opened 158 new positions and closed 145 in Q1 2015.
- Axa's portfolio value fell 2.7% quarter-over-quarter to $24.3B.
Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.